BackSymBio Pharmaceuticals Limited Overview

SymBio Pharmaceuticals Limited Inventory

Latest inventory for SYMQY: $150M.

Get informed when a big investor buys or sells

+ Follow
Inventory
$149.30M
↓ 45.69% YoYΔ $-125.60M vs prior year quarter

Peer trimmed avg / median

Loading

SymBio Pharmaceuticals Limited Inventory History

Loading

SymBio Pharmaceuticals Limited vs. peers: Inventory Comparison

Loading

SymBio Pharmaceuticals Limited Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

SymBio Pharmaceuticals Limited (SYMQY) FAQ

The latest inventory for SYMQY is $150M as of June 2026. That compares with $270M in the prior-year period — down 45.7% year over year. Investors often review this figure alongside SymBio Pharmaceuticals Limited's historical trend and sector peers before judging valuation or financial health.

Over the past year, SYMQY's inventory moved from $270M to $150M — a 45.7% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in SymBio Pharmaceuticals Limited's operating scale or balance-sheet position.

A inventory figure of $150M for SYMQY is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting SYMQY's inventory ($150M), review year-over-year change from $270M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.